Linarol Tablet 5 mg contains Linagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor used for the management of type 2 diabetes mellitus. It is designed for adults whose blood glucose levels are not adequately controlled through diet and exercise alone. Linarol helps regulate both fasting and postprandial blood sugar levels by enhancing the body’s natural incretin system, making it an effective option for maintaining long-term glycemic control.

Linagliptin works by inhibiting the DPP-4 enzyme, which prolongs the activity of incretin hormones such as GLP-1 and GIP. These hormones increase insulin secretion in response to meals and decrease glucagon release, helping the body maintain balanced blood sugar levels. Linarol is well-suited for patients with renal impairment, as it requires no dose adjustment in mild to moderate kidney dysfunction, enhancing its safety and convenience.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Linarol Tablet 5 mg exerts its antidiabetic effect through DPP-4 inhibition:

• Inhibition of DPP-4 enzyme: Prevents the breakdown of incretin hormones (GLP-1 and GIP), prolonging their activity in the body.

• Enhanced insulin secretion: Stimulates the pancreas to release insulin when blood glucose is elevated.

• Suppression of glucagon: Reduces inappropriate glucagon release from the pancreas, decreasing hepatic glucose production.

• Glucose-dependent mechanism: Lowers the risk of hypoglycemia since insulin secretion occurs only when blood sugar is high.

This targeted mechanism ensures effective blood sugar control while minimizing the risk of hypoglycemia compared to other antidiabetic therapies.

Indications

Linarol Tablet 5 mg is indicated for:

• Type 2 diabetes mellitus: As monotherapy when diet and exercise alone are insufficient to control blood sugar.

• Combination therapy: Can be used alongside metformin, sulfonylureas, or insulin to optimize glycemic control.

• Postprandial glucose management: Helps reduce blood sugar spikes after meals.

It is not suitable for type 1 diabetes or for diabetic ketoacidosis.

Dosage and Administration

• The recommended dose is 5 mg once daily, taken orally with or without food.

• Swallow the tablet whole with water; do not crush or chew.

• Dose adjustment is generally not required in patients with renal or mild hepatic impairment.

• Regular monitoring of fasting and postprandial blood glucose, as well as HbA1c, is recommended to assess treatment effectiveness.

• Patients should continue following a healthy diet, exercise, and lifestyle modifications for optimal results.

Precautions

• Consult your physician if you have severe kidney or liver disease, pancreatitis, or a history of hypersensitivity to DPP-4 inhibitors.

• Use caution when combined with other antidiabetic medications, especially sulfonylureas or insulin, as hypoglycemia may occur.

• Inform your doctor about any cardiovascular disease, pancreatitis, or history of severe joint pain.

• The safety of Linagliptin in pregnancy or lactation has not been fully established; consult a healthcare professional before use.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Linarol Tablet 5 mg is generally well tolerated. Common side effects may include:

• Upper respiratory tract infections or nasopharyngitis

• Headache

• Mild gastrointestinal discomfort (nausea, diarrhea)

• Joint pain

Rare but serious side effects include:

• Pancreatitis (symptoms: severe abdominal pain, nausea, vomiting)

• Severe allergic reactions (rash, swelling, difficulty breathing)

• Hypoglycemia (especially when combined with other antidiabetic drugs)

Seek immediate medical attention if severe or persistent symptoms occur.

Storage

Store below 30°C in a dry place, protected from direct sunlight and moisture. Keep out of reach of children.

Linarol Tablet 5 mg provides effective, safe, and convenient management of type 2 diabetes, helping maintain stable blood sugar levels, support pancreatic function, and reduce the risk of long-term complications under medical supervision.